Neurosarcoidosis: Clinical manifestations, diagnosis and treatment

Presse Medicale

Volumn 41, Issue 6 PART 2, 2012, Pages

  Nozaki, Kenkichi ^a   Judson, Marc A ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; HYDROXYCHLOROQUINE; IMMUNOMODULATING AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE;

AUTOIMMUNITY; BONE MARROW SUPPRESSION; CARDIOTOXICITY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; CRANIAL NEUROPATHY; DEMYELINATING DISEASE; DIABETES INSIPIDUS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DRUG CARCINOGENICITY; DRUG SAFETY; EYE TOXICITY; GASTROINTESTINAL SYMPTOM; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GLUCOSE INTOLERANCE; HEADACHE; HEARING LOSS; HEMORRHAGIC CYSTITIS; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; HYPERTENSION; HYPOTHALAMUS DISEASE; INFECTION; LETHARGY; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MENINGITIS; MYELORADICULOPATHY; MYOPATHY; NEUROIMAGING; NEUTROPENIA; OBESITY; OSTEOPOROSIS; PATHOGENESIS; PERIPHERAL NEUROPATHY; PNEUMONIA; PROGNOSIS; PSYCHOSIS; SARCOIDOSIS; SEIZURE; SHORT SURVEY; SIDE EFFECT; TERATOGENICITY; UREMIA;

EID: 84861938701     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.12.017     Document Type: Short Survey

References (100)

1. Judson M.A. Sarcoidosis: clinical presentation, diagnosis, and approach to treatment. Am J Med Sci 2008, 335:26-33.
2. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, 1999. Am J Resp Crit Care Med. 1999;160:736-55.
3. Sharma O.P. Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 1997, 112:220-228.
4. Judson M.A., Baughman R.P., Teirstein A.S., Terrin M.L., Yeager H. Defining organ involvement in sarcoidosis:the Access proposed instrument. Access Research Group. A Case Control Etiologic Study of Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16:75-86.
5. Gullapalli D., Phillips L.H. Neurosarcoidosis. Curr Neurol Neurosci Rep 2004, 4:441-447.
6. Chen R.C., McLeod J.G. Neurological complications of sarcoidosis. Clin Exp Neurol 1989, 26:99-112.
7. Stern B.J, Krumholz A., Johns C., Scott P., Nissim J. Sarcoidosis and its neurological manifestations. Arch Neurol 1985, 42:909-917.
8. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Int Med 1977, 87:336-345.
9. Lower E.E., Broderick J.P., Brott T.G., Baughman R.P. Diagnosis and management of neurological sarcoidosis. Arch Int Med 1997, 157:1864-1868.
10. Allen R.K., Sellars R.E., Sandstrom P.A. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003, 20:118-125.
11. Joseph F.G., Scolding N.J. Neurosarcoidosis: a study of 30 new cases. J Neurol Neurosur Psychiatry 2009, 80:297-304.
12. Ricker W., Clark M. Sarcoidosis: a clinicopathologic review of 300 cases, including 22 autopsies. Am J Clin Pathol 1949, 19:725-749.
13. Smith J.K., Matheus M.G., Castillo M. Imaging manifestations of neurosarcoidosis. AJR 2004, 182:289-295.
14. Moller D.R., Chen E.S. What causes sarcoidosis?. Current opinion in pulmonary medicine 2002, 8:429-434.
15. Moller D.R. Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16:24-31.
16. Doty J.D., Mazur J.E., Judson M.A. Treatment of sarcoidosis with infliximab. Chest 2005, 127:1064-1071.
17. Nowak D.A., Widenka D.C. Neurosarcoidosis: a review of its intracranial manifestation. J Neurol 2001, 248:363-372.
18. Mazziotti S., Gaeta M., Blandino A., Vinci S., Pandolfo I. Perineural spread in a case of sinonasal sarcoidosis: case report. AJNR 2001, 22:1207-1208.
19. Bihan H., Christozova V., Dumas J.L., Jomaa R., Valeyre D., Tazi A., et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine 2007, 86:259-268.
20. Milgrim L.M., Cohen A.F. Nonpulmonary sinonasal sarcoidosis with intracranial invasion. Otolaryngol Head Neck Surg 1996, 114:162-165.
21. Vital A., Lagueny A., Ferrer X., Louiset P., Canron M.H., Vital C. Sarcoid neuropathy: clinico-pathological study of 4 new cases and review of the literature. Clin Neuropathol 2008, 27:96-105.
22. Ferriby D., de Seze J., Stojkovic T., Hachulla E., Wallaert B., Destee A., et al. Long-term follow-up of neurosarcoidosis. Neurology 2001, 57:927-929.
23. Christoforidis G.A., Spickler E.M., Recio M.V., Mehta B.M. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR 1999, 20:655-669.
24. Shah R., Roberson G.H., Cure J.K. Correlation of MR imaging findings and clinical manifestations in neurosarcoidosis. AJNR 2009, 30:953-961.
25. Spencer T.S., Campellone J.V., Maldonado I., Huang N., Usmani Q., Reginato A.J. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Seminars in arthritis and rheumatism 2005, 34:649-661.
26. Zajicek J.P., Scolding N.J., Foster O., Rovaris M., Evanson J., Moseley I.F., et al. Central nervous system sarcoidosis-diagnosis and management. QJM 1999, 92:103-117.
27. Agbogu B.N., Stern B.J., Sewell C., Yang G. Therapeutic considerations in patients with refractory neurosarcoidosis. Arch Neurol 1995, 52:875-879.
28. Scott T.F., Yandora K., Valeri A., Chieffe C., Schramke C. Aggressive therapy for neurosarcoidosis: long-term follow-up of 48 treated patients. Arch Neurol 2007, 64:691-696.
29. Krumholz A., Stern B.J., Stern E.G. Clinical implications of seizures in neurosarcoidosis. Arch Neurol 1991, 48:842-844.
30. Wiederholt W.C., Siekert R.G. Neurological manifestations of sarcoidosis. Neurology 1965, 15:1147-1154.
31. Pawate S., Moses H., Sriram S. Presentations and outcomes of neurosarcoidosis: a study of 54 cases. QJM 2009, 102:449-460.
32. Terushkin V., Stern B.J., Judson M.A., Hagiwara M., Pramanik B., Sanchez M., et al. Neurosarcoidosis: presentations and management. Neurologist 2010, 16:2-15.
33. Gullapalli D., Phillips L.H.J2nd. Neurologic manifestations of sarcoidosis. Neurol Clin 2002, 20(vi):59-83.
34. Cancelli I., Merlino G., Serafini A., Valente M., Gigli G.L. Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient. Neurol Sci 2008, 29:33-35.
35. Brouwer M.C., de Gans J., Willemse R.B., van de Beek D. Neurological picture. Sarcoidosis presenting with hydrocephalus. J Neurol Neurosurg Psychiatry 2009, 80:550-551.
36. Benzagmout M., Boujraf S., Gongora-Rivera F., Bresson D., Van-Effenterre R. Neurosarcoidosis which manifested as acute hydrocephalus: diagnosis and treatment. Intern Med 2007, 46:1601-1604.
37. Westhout F.D., Linskey M.E. Obstructive hydrocephalus and progressive psychosis: rare presentations of neurosarcoidosis. Surg Neurol 2008, 69:92. 288-92; discussion.
38. Rudkin A.K., Wilcox R.A., Slee M., Kupa A., Thyagarajan D. Relapsing encephalopathy with headache: an unusual presentation of isolated intracranial neurosarcoidosis. J Neurol Neurosur Psychiatry 2007, 78:770-771.
39. Cox C.E., Donohue J.F., Brown C.D., Kataria Y.P., Judson M.A. Health-related quality of life of persons with sarcoidosis. Chest 2004, 125:997-1004.
40. Chang B., Steimel J., Moller D.R., Baughman R.P., Judson M.A., Yeager H., et al. Depression in sarcoidosis. Am J Resp Crit Care Med 2001, 163:329-334.
41. Murialdo G., Tamagno G. Endocrine aspects of neurosarcoidosis. J Endocrinol Invest 2002, 25:650-662.
42. Porter N., Beynon H.L., Randeva H.S. Endocrine and reproductive manifestations of sarcoidosis. QJM 2003, 96:553-561.
43. Fery F., Plat L., van de Borne P., Cogan E., Mockel J. Impaired counterregulation of glucose in a patient with hypothalamic sarcoidosis. N Engl J Med 1999, 340:852-856.
44. Varron L., Broussolle C., Candessanche J.P., Marignier R., Rousset H., Ninet J., et al. Spinal cord sarcoidosis: report of seven cases. Eur J Neurol 2009, 16:289-296.
45. Nagai H., Ohtsubo K., Shimada H. Sarcoidosis of the spinal cord. Report of an autopsy case and review of the literature. Acta Pathologica Japonica 1985, 35:1007-1022.
46. Ku A., Lachmann E., Tunkel R., Nagler W. Neurosarcoidosis of the conus medullaris and cauda equina presenting as paraparesis: case report and literature review. Paraplegia 1996, 34:116-120.
47. Koffman B., Junck L., Elias S.B., Feit H.W., Levine S.R. Polyradiculopathy in sarcoidosis. Muscle Nerve 1999, 22:608-613.
48. Burns T.M., Dyck P.J., Aksamit A.J. The natural history and long-term outcome of 57 limb sarcoidosis neuropathy cases. J Neurol Sci 2006, 244:77-87.
49. Tavee J., Culver D. Sarcoidosis and small-fiber neuropathy. Curr Pain Headache Rep 2011, 15:201-206.
50. Hoitsma E., Faber C.G., van Kroonenburgh M.J., Gorgels A.P., Halders S.G., Heidendal G.A., et al. Association of small fiber neuropathy with cardiac sympathetic dysfunction in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005, 22:43-50.
51. Judson M.A. Small fiber neuropathy in sarcoidosis: something beneath the surface. Resp Med 2011, 105:1-2.
52. Fayad F., Liote F., Berenbaum F., Orcel P., Bardin T. Muscle involvement in sarcoidosis: a retrospective and follow-up studies. J Rheumatol 2006, 33:98-103.
53. Berger C., Sommer C., Meinck H.M. Isolated sarcoid myopathy. Muscle Nerve 2002, 26:553-556.
54. Vattemi G., Tonin P., Marini M., Guadagnin M.L., Dal Pra B., Simonati A., et al. Sarcoidosis and inclusion body myositis. Rheumatology (Oxford) 2008, 47:1433-1435.
55. Baumann R.J., Robertson W.C. Neurosarcoid presents differently in children than in adults. Pediatrics 2003, 112:e480-e486.
56. Cohen-Aubart F., Galanaud D., Grabli D., Haroche J., Amoura Z., Chapelon-Abric C., et al. Spinal cord sarcoidosis: clinical and laboratory profile and outcome of 31 patients in a case-control study. Medicine 2010, 89:133-140.
57. Huang C.T., Heurich A.E., Sutton A.L., Lyons H.A. Mortality in sarcoidosis. A changing pattern of the causes of death. Eur J Respir Dis 1981, 62:231-238.
58. Marangoni S., Argentiero V., Tavolato B. Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol 2006, 253:488-495.
59. Scott T.F., Yandora K., Kunschner L.J., Schramke C. Neurosarcoidosis mimicry of multiple sclerosis: clinical, laboratory, and imaging characteristics. Neurologist 2010, 16:386-389.
60. Smith A.S., Meisler D.M., Weinstein M.A., Tomsak R.L., Hanson M.R., Rudick R.A., et al. High-signal periventricular lesions in patients with sarcoidosis: neurosarcoidosis or multiple sclerosis?. AJR 1989, 153:147-152.
61. Volker H.U., Kraft K., Arnold E., Steinhoff S., Kolios G., Sommer S. Progressive multifocal leukoencephalopathy developing in advanced pulmonal sarcoidosis. Clin Neurol Neurosurg 2007, 109:624-630.
62. Mozaffar T., Lopate G., Pestronk A. Clinical correlates of granulomas in muscle. J Neurol 1998, 245:519-524.
63. Le Roux K., Streichenberger N., Vial C., Petiot P., Feasson L., Bouhour F., et al. Granulomatous myositis: a clinical study of thirteen cases. Muscle Nerve 2007, 35:171-177.
64. Siltzbach L.E. The Kveim test in sarcoidosis. A study of 750 patients. JAMA 1961, 178:476-482.
65. Chapelon C., Ziza J.M., Piette J.C., Levy Y., Raguin G., Wechsler B., et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicine 1990, 69:261-276.
66. Judson M.A. Hepatic and splenic sarcoidosis. Sarcoidosis. Lung Biopsy in Health and Disease 2006, 210:571-592. Marcel Dekker, New York. R.P. Baughman (Ed.).
67. Pickuth D., Heywang-Kobrunner S.H. Neurosarcoidosis: evaluation with MRI. J Neuroradiol 2000, 27:185-188.
68. Braun J.J., Kessler R., Constantinesco A., Imperiale A. 18F-FDG PET/CT in sarcoidosis management: review and report of 20 cases. Eur J Nucl Med Mol Imaging 2008, 35:1537-1543.
69. Teirstein A.S., Machac J., Almeida O., Lu P., Padilla M.L., Iannuzzi M.C. Results of 188 whole-body fluorodeoxyglucose positron emission tomography scans in 137 patients with sarcoidosis. Chest 2007, 132:1949-1953.
70. Dumas J.L., Valeyre D., Chapelon-Abric C., Belin C., Piette J.C., Tandjaoui-Lambiotte H., et al. Central nervous system sarcoidosis: follow-up at MR imaging during steroid therapy. Radiology 2000, 214:411-420.
71. Sherman J.L., Stern B.J. Sarcoidosis of the CNS: comparison of unenhanced and enhanced MR images. AJR 1990, 155:1293-1301.
72. Khoury J., Wellik K.E., Demaerschalk B.M., Wingerchuk D.M. Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist 2009, 15:108-111.
73. Dale J.C., O'Brien J.F. Determination of angiotensin-converting enzyme levels in cerebrospinal fluid is not a useful test for the diagnosis of neurosarcoidosis. Mayo Clin Proc 1999, 74:535.
74. Tahmoush A.J., Amir M.S., Connor W.W., Farry J.K., Didato S., Ulhoa-Cintra A., et al. CSF-ACE activity in probable CNS neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002, 19:191-197.
75. Gould H., Kaufman H.E. Sarcoid of the fundus. Arch Ophthalmol 1961, 65:453-456.
76. Menezo V., Lobo A., Yeo T.K., du Bois R.M., Lightman S. Ocular features in neurosarcoidosis. Ocul Immunol Inflamm 2009, 17:170-178.
77. Devigili G., Tugnoli V., Penza P., Camozzi F., Lombardi R., Melli G., et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 2008, 131:1912-1925.
78. Reulen J.P., Lansbergen M.D., Verstraete E., Spaans F. Comparison of thermal threshold tests to assess small nerve fiber function: limits vs. levels. Clin Neurophysiol 2003, 114:556-563.
79. Truini A., Galeotti F., Romaniello A., Virtuoso M., Iannetti G.D., Cruccu G. Laser-evoked potentials: normative values. Clin Neurophysiol 2005, 116:821-826.
80. Atherton D.D., Facer P., Roberts K.M., Misra V.P., Chizh B.A., Bountra C., et al. Use of the novel Contact Heat Evoked Potential Stimulator (CHEPS) for the assessment of small fibre neuropathy: correlations with skin flare responses and intra-epidermal nerve fibre counts. BMC Neurol 2007, 7:21.
81. Low P.A., Caskey P.E., Tuck R.R., Fealey R.D., Dyck P.J. Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983, 14:573-580.
82. Lauria G., Cornblath D.R., Johansson O., McArthur J.C., Mellgren S.I., Nolano M., et al. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 2005, 12:747-758.
83. Ebenezer G.J., Hauer P., Gibbons C., McArthur J.C., Polydefkis M. Assessment of epidermal nerve fibers: a new diagnostic and predictive tool for peripheral neuropathies. J Neuropathol Exp Neurol 2007, 66:1059-1073.
84. Doty J.D., Mazur J.E., Judson M.A. Treatment of corticosteroid-resistant neurosarcoidosis with a short-course cyclophosphamide regimen. Chest 2003, 124:2023-2026.
85. Lewis S.J., Ainslie G.M., Bateman E.D. Efficacy of azathioprine as second-line treatment in pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999, 16:87-92.
86. Muller-Quernheim J., Kienast K., Held M., Pfeifer S., Costabel U. Treatment of chronic sarcoidosis with an azathioprine/prednisolone regimen. Eur Respir J 1999, 14:1117-1122.
87. Sodhi M., Pearson K., White E.S., Culver D.A. Infliximab therapy rescues cyclophosphamide failure in severe central nervous system sarcoidosis. Resp Med 2009, 103:268-273.
88. Santos E., Shaunak S., Renowden S.A., Scolding N.J. Treatment of refractory neurosarcoidosis with infliximab. J Neurol Neurosurg Psychiatry 2010, 81:241-246.
89. Pereira J., Anderson N.E., McAuley D., Bergin P., Kilfoyle D., Fink J. Medically refractory neurosarcoidosis treated with infliximab. Intern Med J 2011, 41:354-357.
90. Chintamaneni S., Patel A.M., Pegram S.B., Patel H., Roppelt H. Dramatic response to infliximab in refractory neurosarcoidosis. Ann Indian Acad Neurol 2010, 13:207-210.
91. Nozaki K., Silver R.M., Stickler D.E., Abou-Fayssal N.G., Giglio P., Kamen D.L., et al. Neurological deficits during treatment with tumor necrosis factor-alpha antagonists. AmJ Med Sci 2011, 342:352-355.
92. Corbett J. Treating CNS sarcoidosis with infliximab and mycophenolate mofetil. Curr Neurol Neurosci Rep 2009, 9:339-340.
93. Moravan M., Segal B.M. Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil. Neurology 2009, 72:337-340.
94. Chaussenot A., Bourg V., Chanalet S., Fornari J.M., Lebrun C. Neurosarcoïdose et mycophénolate mofétil. Rev Neurol (Paris) 2007, 163:471-475.
95. Androdias G., Maillet D., Marignier R., Pinede L., Confavreux C., Broussolle C., et al. Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy. Neurology 2011, 76:1168-1172.
96. Sharma O.P. Effectiveness of chloroquine and hydroxychloroquine in treating selected patients with sarcoidosis with neurological involvement. Arch Neurol 1998, 55:1248-1254.
97. Parambil J.G., Tavee J.O., Zhou L., Pearson K.S., Culver D.A. Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Resp Med 2011, 105:101-105.
98. Hoitsma E., Faber C.G., van Santen-Hoeufft M., De Vries J., Reulen J.P., Drent M. Improvement of small fiber neuropathy in a sarcoidosis patient after treatment with infliximab. Sarcoidosis Vasc Diffuse Lung Dis 2006, 23:73-77.
99. Menninger M.D., Amdur R.J., Marcus R.B. Role of radiotherapy in the treatment of neurosarcoidosis. Am J Clin Oncol 2003, 26:e115-e118.
100. Stelzer K.J., Thomas C.R., Berger M.S., Spence A.M., Shaw C.M., Griffin T.W. Radiation therapy for sarcoid of the thalamus/posterior third ventricle: case report. Neurosurgery 1995, 36:1188-1191.